AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL – Get Free Report)’s share price shot up 1.1% during mid-day trading on Tuesday . The company traded as high as $19.40 and last traded at $19.35. 629,672 shares were traded during mid-day trading, an increase of 64% from the average session volume of 383,923 shares. The stock had previously closed at $19.14.
AGF U.S. Market Neutral Anti-Beta Fund Price Performance
The firm’s 50 day moving average price is $19.77 and its 200 day moving average price is $19.58. The stock has a market capitalization of $275.70 million, a P/E ratio of 15.45 and a beta of -0.85.
Hedge Funds Weigh In On AGF U.S. Market Neutral Anti-Beta Fund
Several hedge funds and other institutional investors have recently modified their holdings of BTAL. Creative Financial Designs Inc. ADV raised its holdings in AGF U.S. Market Neutral Anti-Beta Fund by 8.8% in the third quarter. Creative Financial Designs Inc. ADV now owns 158,626 shares of the company’s stock worth $3,109,000 after purchasing an additional 12,788 shares in the last quarter. VitalStone Financial LLC increased its stake in shares of AGF U.S. Market Neutral Anti-Beta Fund by 48.5% in the 3rd quarter. VitalStone Financial LLC now owns 85,335 shares of the company’s stock worth $1,673,000 after acquiring an additional 27,885 shares in the last quarter. Worth Asset Management LLC lifted its position in AGF U.S. Market Neutral Anti-Beta Fund by 16.2% during the 3rd quarter. Worth Asset Management LLC now owns 41,346 shares of the company’s stock valued at $810,000 after acquiring an additional 5,760 shares during the period. Waterloo Capital L.P. bought a new stake in AGF U.S. Market Neutral Anti-Beta Fund during the second quarter worth about $477,000. Finally, Toronto Dominion Bank grew its holdings in AGF U.S. Market Neutral Anti-Beta Fund by 352.8% in the first quarter. Toronto Dominion Bank now owns 3,930 shares of the company’s stock worth $71,000 after purchasing an additional 3,062 shares during the period.
About AGF U.S. Market Neutral Anti-Beta Fund
The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.
Further Reading
- Five stocks we like better than AGF U.S. Market Neutral Anti-Beta Fund
- Investing in Commodities: What Are They? How to Invest in Them
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- Are Penny Stocks a Good Fit for Your Portfolio?
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for AGF U.S. Market Neutral Anti-Beta Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGF U.S. Market Neutral Anti-Beta Fund and related companies with MarketBeat.com's FREE daily email newsletter.
